eCQMs for 2020 Performance Period CMS2v9 CMS22v8 CMS50v8 CMS52v8 CMS56v8 CMS66v8 CMS68v9 CMS69v8 CMS74v9 CMS75v8 CMS82v7 CMS90v9 CMS117v8 CMS122v8 CMS124v8 CMS125v8 CMS127v8 CMS128v8 CMS129v9 CMS130v8 CMS131v8 CMS132v8 CMS133v8 CMS134v8 CMS135v8 CMS136v9 CMS137v8 CMS138v8 CMS139v8 CMS142v8 CMS143v8 CMS144v8 CMS145v8 CMS146v8 CMS147v9 CMS149v8 CMS153v8 CMS154v8 CMS155v8 CMS156v8 CMS157v8 CMS159v8 CMS160v8 CMS161v8 CMS165v8 CMS177v8 CMS249v2 CMS347v3 CMS349v2 CMS645v3 CMS771v1 CMS Measure ID CMS771v1 Version 1 NQF Number Not Applicable Measure Description Percentage of patients with an office visit within the measurement period and with a new diagnosis of clinically significant Benign Prostatic Hyperplasia who have International Prostate Symptoms Score (IPSS) or American Urological Association (AUA) Symptom Index (SI) documented at time of diagnosis and again 6-12 months later with an improvement of 3 points Initial Population Male patients with an initial diagnosis of benign prostatic hyperplasia 6 months prior to, or during the measurement period, and a urinary symptom score assessment within 1 month of initial diagnosis and a follow-up urinary symptom score assessment within 6-12 months, who had a qualifying visit during the measurement period. Denominator Statement Equals initial population Denominator Exclusions Patients with urinary retention that starts within 1 year of initial BPH diagnosis Patients with an initial BPH diagnosis that starts during, or within 30 days of hospitalization Patients with a diagnosis of morbid obesity, or with a BMI Exam >40 before the follow up urinary symptom score. Numerator Statement Patients with a documented improvement of at least 3 points in their urinary symptom score during the measurement period Numerator Exclusions None Denominator Exceptions None Domain Person and Caregiver-Centered Experience and Outcomes Measure Scoring Proportion Measure Type Outcome Improvement Notation A meaningful improvement is a negative 3 point change in the urinary symptom score. The quality improves when a higher proportion of people meet the meaningful improvement definition. Guidance The IPSS is inclusive of the symptom index score and the quality of life score. The AUA-SI is the symptom index score alone and must be added to the QOL score. The AUA-SI with the QOL equals the IPSS. Both of these are the urinary symptom score. The patient must have a urinary symptom score (USS) within 1 month after initial diagnosis. If more than one USS in the initial one month, then the first USS counts. The patient must have a USS again at 6-12 months after the initial diagnosis and if more than one USS in this time frame, then the last USS counts. Hospitalization within 30 days of Initial BPH Diagnosis refers to a 30 day period between the end of the hospitalization and the clinical office setting BPH diagnosis. This is due to aggravating factors from hospitalization, such as bed rest, medications, surgery, and altered body functions. Quality ID TBD Meaningful Measure Functional Outcomes Specifications Attachment Size CMS771v1.html 60.65 KB CMS771v1.zip 40.31 KB External Resources United States Health Information Knowledgebase NLM Value Set Authority Center (VSAC)